Mankind Pharma Assigned ESG Rating of 64.8 by SES for FY26
Mankind Pharma Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 6:55 pm
Mankind Pharma Assigned ESG Rating of 64.8 by SES for FY26 Mankind Pharma announced on 5th Nov'26 that SEBI-registered ESG rating provider SES ESG Research Private Limited has assigned the company an Environmental, Social, and Governance (ESG) rating of 64.8 for FY26. The rating was independently assigned by SES based solely on publicly available information, without any engagement or solicitation from the company.
Original exchange filing (PDF)
More announcements from Mankind Pharma Ltd
- Please find attached intimation regarding change in Corporate Office Address of RTA 路 13 Nov 2026
- Please find attached Intimation of participation in the Investor Conference 路 06 Nov 2026
- Intimation of participation in the Investor Conference. 路 03 Nov 2026
- Please find attached transcript of the Earnings Conference Call for Q2 & H1 FY27 路 30 Oct 2026
- Please find attached intimation regarding re-affirmation/withdrawl of Credit Rating by CRISIL 路 30 Oct 2026
- In continuation of our earlier intimation dated October 22, 2026 please find attached the Investor Presentation to be made during the said Analyst / Institutional Investors meet 路 27 Oct 2026
- Please find attached link for audio recording of the Investor Conference Call held on October 26, 2026 路 27 Oct 2026
- Investor Presentation on Financial Results of the Company for Q2 & H1FY27 路 26 Oct 2026
